INSIGHTS ON DRUG DEVELOPMENT
-
Rapid Automated Selection Of Mammalian Cell Colonies
Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.
-
Assessing Viability And Real-Time Apoptosis/Necrosis
Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.
-
Getting The Most Out Of Cell-Based Assays With The Optimal Read Function
Gain insight into a whole-well fluorescence analysis that improves sensitivity and reproducibility in cell-based assays by accounting for uneven cell distribution.
-
Integrating High-Content Imaging With Traditional Plate-Based Screening
Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.
-
Isolate Bright GFP-Expressing HEK293 Cells For Cell Line Development Workflow11/7/2025
Explore a high-efficiency workflow for isolating and expanding GFP-expressing HEK293 cells that enables stable, bright clones ideal for imaging and tracking to simplify clonal development.
-
Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates12/11/2024
Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.
-
Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery6/3/2025
Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.
-
Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions6/16/2025
Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.
-
Aggregation In Antibody-Drug Conjugates: Causes And Mitigation9/1/2025
Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.
DRUG DEVELOPMENT SOLUTIONS
-
Discover the nanoparticle engineering, formulation and GMP manufacturing services that can drive forward your market success and unlock the power of “small."
-
Multicolor Multiphoton gets you closer to the truth
The combination of multiple distinct fluorescent labels is increasingly used to study dynamic interaction and spatial relationships among cells and molecules. The goal is to understand a myriad of complex biological events, such as cellular connectivity, cell phenotyping, protein interaction or co-expression, and co-localization. Scaling up such studies to whole organs or tissues requires suitable large-volume multicolor microscopy methods. DIVE and STELLARIS have now merged to provide you with the power of flexible multicolor multiphoton imaging. Furthermore, you can expand the potential of your experiments with additional label-free imaging capabilities.
Seamlessly integrated into the confocal software interface, STELLARIS 8 DIVE multiphoton microscope offers the benefits of high speed and excellent navigation so that dynamic processes in complex samples can be studied with ease. STELLARIS 8 DIVE – A rainbow of possibilities for your research.
-
Tailored support is available for diverse molecules, including small and large molecules, nucleic acid therapies, and novel delivery systems. Services span drug substance to regulatory affairs.
-
Explore an expansion service with experts that will work closely with you to customize your process and meet your unique needs by adjusting protocols, optimizing conditions, and providing personalized support.
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.